Cargando…
Transcriptome profiling for precision cancer medicine using shallow nanopore cDNA sequencing
Transcriptome profiling is a mainstay of translational cancer research and is increasingly finding its way into precision oncology. While bulk RNA sequencing (RNA-seq) is widely available, high investment costs and long data return time are limiting factors for clinical applications. We investigated...
Autores principales: | Mock, Andreas, Braun, Melissa, Scholl, Claudia, Fröhling, Stefan, Erkut, Cihan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911782/ https://www.ncbi.nlm.nih.gov/pubmed/36759549 http://dx.doi.org/10.1038/s41598-023-29550-8 |
Ejemplares similares
-
Transcriptome profiling of mouse samples using nanopore sequencing of cDNA and RNA molecules
por: Sessegolo, Camille, et al.
Publicado: (2019) -
Nanopore sequencing of RNA and cDNA molecules in Escherichia coli
por: Grünberger, Felix, et al.
Publicado: (2022) -
Improved Nanopore full-length cDNA sequencing by PCR-suppression
por: Bayega, Anthony, et al.
Publicado: (2022) -
Components of variance in transcriptomics based on electrophoretic separation of cDNA fragments (cDNA-AFLP)
por: Weiberg, Arne, et al.
Publicado: (2009) -
ReorientExpress: reference-free orientation of nanopore cDNA reads with deep learning
por: Ruiz-Reche, Angel, et al.
Publicado: (2019)